‘Liquid Electronic Cigarettes’ Turns Out to Be Drugs…Police Form ‘New Drug Response Council’
The police in South Korea have formed a council to tackle the rising distribution of new psychoactive substances disguised as products like liquid electronic cigarettes and eyelash adhesive remover.
Recent reports indicate a concerning rise in the domestic distribution of new psychoactive substances disguised as common products, notably liquid electronic cigarettes and eyelash adhesive removers. In response to this trend, the National Investigation Agency of the National Police Agency has established a 'New Drug Response Council' in collaboration with various agencies to devise effective countermeasures. The statistics show a significant increase in the amount of seized psychoactive substances—rising from 381 kg in 2024 to 448 kg in the previous year, alongside an increase in arrests related to these offenses.
The rise in drug crimes utilizing disguised products has escalated, with the Seoul Metropolitan Police's drug investigation unit apprehending ten individuals involved in manufacturing illicit drugs by mixing professional drugs like etomidate and propofol into liquid cigarettes for distribution to nightlife venues in Gangnam. Additionally, law enforcement has successfully identified various criminals involved in distributing drugs disguised as jelly or eyelash adhesive removers, marking a worrying trend in drug trafficking methods.
In light of these developments, the police articulated a strategy to proactively intercept imported new drugs through joint crackdowns in collaboration with the Customs Service, focusing on monitoring illegal advertising and sales channels associated with disguised drugs. To mitigate legal loopholes, new substances entering the market will be designated as temporary drugs by the National Institute of Scientific Investigation. The acting Police Chief, Yoo Jae-sung, emphasized the urgency of a comprehensive and collaborative response among agencies to address the ongoing threats posed by these emerging drug trends.